StreetAlpha.app
Home › Stocks › LNTH

Lantheus Holdings, Inc. (LNTH)

Healthcare
Members
LATEST PRICE

Lantheus makes radiopharmaceutical imaging agents and cancer products for hospitals, imaging centers and doctors. LNTH reports earnings on Thu, Nov 5, 2026. Analyst consensus is Hold, based on the latest ratings from 4 firms (1 buy, 3 hold, 0 sell). In the past 30 days there were 5 dark pool prints.

Prices, price targets and earnings estimates for LNTH are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plans
AI Auto Pilots
Is LNTH in one of our four AI portfolios? Sign in free to see
Next report
Nov 5
2026 · Time not announced
Consensus EPS forecast
EPS and revenue estimates
Year-ago EPS
Same quarter last year
Options-implied move
Move priced in by options
Analyst consensus
Hold
Based on 4 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Hold
4firms
1 Buy3 Hold0 Sell
Each firm's latest rating on LNTH in the past 90 days
Average 12-month target
Price targets for LNTHThe average, highest and lowest analyst targets and the target chart are shown to AI Starter and AI Pro members.See plans
Latest rating changes
MizuhoDowngrade
Oct 13Hold
Redburn AtlanticInitiated
Sep 25Buy
Truist SecuritiesDowngrade
Aug 4Hold
TD CowenDowngrade
Aug 3Hold
Truist SecuritiesMaintained
Jul 16Buy
DateFirmActionRatingPrice target
Oct 13MizuhoDowngradeHold
Sep 25Redburn AtlanticInitiatedBuy
Aug 4Truist SecuritiesDowngradeHold
Aug 3TD CowenDowngradeHold
Jul 16Truist SecuritiesMaintainedBuy
Loading…

Whale Options Flow

90D

No whale options trades in LNTH in the last 90 days.

Loading…

Dark Pool

30D
Prints
5
Notional
Largest print
Loading…

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LNTH is in one of them and how their past LNTH trades turned out.

LNTH in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered LNTH in an article yet. Here's the latest on the wider market.

LNTH Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Feb 12
Who traded LNTH · since 2025
Latest 4 filings
$1K – $15KTraded Jan 28, 2025Filed Feb 12, 2025
$1K – $15KTraded Jan 13, 2025Filed Feb 12, 2025
$1K – $15KTraded Jan 8, 2025Filed Feb 12, 2025
$1K – $15KTraded Jan 7, 2025Filed Feb 12, 2025
PersonTypeAmountTradedFiledDelay
Gilbert CisnerosD · CABuy$1K – $15KJan 28, 2025Feb 12, 202515 d
Gilbert CisnerosD · CABuy$1K – $15KJan 13, 2025Feb 12, 202530 d
Gilbert CisnerosD · CABuy$1K – $15KJan 8, 2025Feb 12, 202535 d
Gilbert CisnerosD · CABuy$1K – $15KJan 7, 2025Feb 12, 202536 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Lantheus Holdings

Lantheus is a company focused on radiopharmaceuticals, which are medicines that contain small amounts of radioactive material and are used in medical imaging and cancer care. Its products include diagnostic imaging agents that help doctors detect and characterize disease, including an agent for Alzheimer's disease, along with products for cancer care. Lantheus sells mainly to hospitals, independent imaging centers and government facilities, and its products are used by radiologists, oncologists and nuclear medicine physicians. The company is based in Bedford, Massachusetts.

Headquarters
Bedford, MA